Select a year:

Discover 4P-Pharma’s clinical vision

4P-Pharma is thrilled to share the last video of company portrait galleries realized in collaboration with the magazine Entreprendre to highlight our innovative company activities and story. This video focuses on our clinical vision, aiming to rapidly deliver effective, regenerated, first-in-class therapies for untreated serious diseases with high unmet medical needs. 4P-Pharma has developed a&hellip

Read More

4Moving Biotech at the OARSI Connect 2021 online event

A poster on our latest results on 4P004 entitled « Liraglutide Has Potent Anti-inflammatory And Anti-catabolic Activity In Two Cell Types Implicated In Osteoarthritis » (#435) will be presented during the OARSI Connect online event on 2021 April 29-May 1, by Pr. Francis Berenbaum (4Moving Biotech’s CEO/CMO, Head of Rheumatology department at Saint-Antoine Hospital, and Professor of Rheumatology at Sorbonne University, in Paris, France).&hellip

Read More

4P-Pharma received the Seal of Excellence from the European Commission

4P-Pharma received the Seal of Excellence from the European Commission for its application related to the development of a disease modifier treatment for osteoarthritis, 4P-004 to the Horizon 2020 EIC Accelerator (SME instrument). Following evaluation by an international panel of independent experts, 4P-Pharma’s project was scored as a high-quality proposal in this highly competitive evaluation&hellip

Read More

4P-Pharma at the 3rd International Symposium Research on Healthy Ageing – Longevity Symposium

A poster on 4P-004 entitled “Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies” will be presented during the 3rd International Symposium Research on Healthy Ageing – Longevity Symposium in Institut Pasteur de Lille, France, December 11th-12th 2019, by our Research Assistant, Coralie Meurot (PhD student). For further information, please feel free to contact our&hellip

Read More

4P-Pharma presents 4P-004 data at the ACR/ARP Annual Meeting in Atlanta

A poster on 4P-004 entitled “Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies” (#1973) will be presented during the ACR/ARP Annual Meeting in Atlanta, Georgia November 8 – 13, 2019, by Pr. Francis Berenbaum (Professor of Rheumatology at Sorbonne University, in Paris (France)). For further information, please click on the following link:  

Read More